Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Plug Occlusion of Anal Fistula Shows Mixed Results

By HospiMedica International staff writers
Posted on 16 Feb 2014
A new study reveals that using a collagen anal fistula plug as a means of obliterating the fistula tract and promoting healing has unexplained variations.

Researchers at the Karolinska Institutet (KI; Stockholm, Sweden), Danderyd Hospital (Stockholm, Sweden), and other institutions conducted a retrospective multicenter study involving 126 patients (mean age 47 years) in four Stockholm hospitals who underwent an anal plug fistula procedure between June 2006 and June 2010. More...
Of these patients, 85% were cryptoglandular, 64% were male, and had a mean 2.9 previous fistula procedures. The outcome after first plug insertion was assessed by chart review performed at a minimum of eight months after insertion, and hazard models were used to assess associations of various factors with fistula healing.

The results showed that after a median time of 13 months, 30 (24%) fistulae were closed without discomfort or secretion; the outcome in the four hospitals varied between 13% and 33% for a similar numbers of patients. Patients with an anterior fistula experienced a success rate of 12% compared with 32% of those with posterior tracks, and 41% of those with a lateral internal opening. Age, sex, and number of previous procedures were not associated with healing. The study was published on February 11, 2014, in Colorectal Disease.

“The Biodesign anal fistula plug was introduced as a means of obliterating the fistula tract and promote healing through biocompatibility,” concluded lead author Johannes Blom, MD, PhD, of the KI Center of Surgical Gastroenterology, and colleagues. “The results demonstrated unexplained variations from good to bad; anterior fistulae were much less likely to heal than fistulae in other locations.”

The Biodesign anal fistula plug used in the study acts as a scaffold, allowing tissue to grow and close the fistula tract. The result is remodeled, vascularized tissue and fistula closure without the muscle damage from surgery that can lead to incontinence. The plug is designed to keep the sphincter intact and restores natural form and function with minimal scar tissue formation. The Biodesign anal fistula plug is a product of Cook Medical (Bloomington, IN, USA), and is available with or without retention button.

Related Links:

Karolinska Institutet
Danderyd Hospital
Cook Medical



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.